Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy

NCT07220785 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Lipodystrophy

Interventions

DRUG: Mibavademab
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals